Welcome to our dedicated page for Zalatoris Acquisition news (Ticker: TCOA), a resource for investors and traders seeking the latest updates and insights on Zalatoris Acquisition stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Zalatoris Acquisition's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Zalatoris Acquisition's position in the market.
Summary not available.
Summary not available.
Trajectory Alpha Acquisition Corp. (NYSE:TCOA) was notified by the New York Stock Exchange on January 12, 2023, of non-compliance concerning the minimum requirement of 300 public stockholders. This notification does not impact the Company’s business operations. TCOA has 45 days to outline a plan to rectify this situation within 18 months, during which its stock will continue to trade on the NYSE. The Company anticipates reaching the required number of stockholders post its initial business combination. Despite this issue, the notification does not affect TCOA's SEC reporting obligations.
Trajectory Alpha Acquisition Corp. announced that starting January 31, 2022, holders of its 17,250,000 initial public offering units can trade shares of Class A common stock and public warrants separately. The shares will trade under the symbols TCOA for common stock and TCOA WS for public warrants on the New York Stock Exchange. Units that remain unchanged will continue trading under the symbol TCOA.U. This process does not involve fractional public warrants, only whole warrants will be available for trade.
Trajectory Alpha Acquisition Corp. announced the pricing of its initial public offering (IPO) of 15,000,000 units at $10.00 each, targeting $150 million. Trading on the New York Stock Exchange under the ticker symbol TCOA.U is set to begin on December 10, 2021. Each unit includes one share of Class A common stock and one-half of one public warrant. The management team, with over 80 years of experience, aims to acquire a disruptive technology-driven business. The offering is expected to close on December 14, 2021, with underwriters granted a 45-day option for additional units.